Participants 31 96 4
positron emission tomography-negative stage I/II Hodgkin lymphoma
Participants 311 366 4
patients with clinical stage I/II Hodgkin lymphoma (HL)
Participants 666 790 4
patients attaining a negative early PET scan after two cycles of ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine)
Participants 867 946 6
Patients age 15 to 70 years with untreated clinical stage I/II HL were eligible
Participants 1301 1315 7
1,137 patients
